Results 131 to 140 of about 2,807 (182)

Tertiary lymphoid structure can be a potential therapeutic target for head and neck squamous cell carcinoma (Review). [PDF]

Mol Clin Oncol
Shen J, Yang X.
europepmc   +1 more source

Artemisinin-Related Therapeutic Strategies for Autoimmune Thyroiditis: Chemokine-Receptor Networks, Spatial Thyroid Biology, and Molecular Mechanisms. [PDF]

Drug Des Devel Ther
Sun Y, Yang X, Zhu Q, Yang R.
europepmc   +1 more source

The CXCL13 hub in obesity-related metabolic inflammation: regulation of spatiotemporal heterogeneity and targeted strategies. [PDF]

J Endocrinol
Huang M, Chen X, Jiang Y, Liu T.
europepmc   +1 more source

Metachronous bilateral renal cancer with immune checkpoint blockade-mediated eradication of bone metastasis: case report. [PDF]

Front Oncol
Metodiev D, Borisov T, Da Costa PA, Redissi A, Cremer I, Petrova M, Vano YA, Roumenina LT, Ferdinandov D.   +8 more
europepmc   +1 more source

Tertiary lymphoid structures are associated with lower axillary residual nodal burden in breast cancer patients after neoadjuvant chemotherapy. [PDF]

Eur J Med Res
Wei Z, Lin K, Deng W, Chen Y, Lu Y.
europepmc   +1 more source

Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome. [PDF]

Gut
Milardi G, Franceschini B, Camisaschi C, Puccio S, Costa G, Soldani C, Uva P, Cangelosi D, Carriero R, Lambroia L, Cammarota A, Lodetti-Zangrandi G, Malenica I, Erreni M, Montali I, Lottini T, Raggi C, Kunderfranco P, Polidoro MA, Aghemo A, Balsano R, Pressiani T, Piscuoglio S, Piscuoglio S, Di Tommaso L, Torzilli G, Rimassa L, Lugli E, Cassani B, Lleo A.   +29 more
europepmc   +1 more source

From mechanisms to therapy: the role of tertiary lymphoid structures in bladder cancer. [PDF]

World J Surg Oncol
Yang J, Li X, Xie H, Guo J, Wang J, Lin C.   +5 more
europepmc   +1 more source

Immunogenic cell death as a cornerstone for combination therapies with immune checkpoint blockade. [PDF]

Mol Cancer
Niu Y, Zhu S, Fu K, Lai Y, Pan C, Yang Y, Li S, Wang X, To KKW, Wang F, Fu L.   +10 more
europepmc   +1 more source